ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional ...

In Greek mythology, King Sisyphus was condemned by the god Zeus to spend eternity rolling a boulder up a hill only to have it roll back down, having to start anew every day. His story captured our ...

The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...

A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind ...

ARPA-H award supports the development of an oral prodrug, based on the Glyph™ platform initially developed at the Monash Institute of Pharmaceutical ...

Researchers are urging more study into whether a surgical procedure called LVA may be repurposed as a potential Alzheimer's ...

The Government of Jharkhand has intensified efforts to eliminate Lymphatic Filariasis through a renewed phase of the Mass Drug Administration campaign.

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...

Replying to a private member’s resolution moved by Kumar Waii in the Arunachal Pradesh Legislative Assembly seeking urgent ...

In Greek mythology, King Sisyphus was condemned by the god Zeus to spend eternity rolling a boulder up a hill only to have it roll back down, having ...

A small but growing body of evidence suggests that a minimally invasive surgical procedure called lymphovenous anastomosis (LVA) might be an effective treatment for Alzheimer's disease (AD). This is ...

Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...